Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.

Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.
复制标题

心肌梗塞和心力衰竭中的基质金属蛋白酶。

DOI:
10.1016/bs.pmbts.2017.02.001
复制
发表时间:
2017
影响因子:
--
通讯作者:
Lindsey ML
Lindsey ML
中科院分区:
生物学3区
文献类型:
--
作者:
DeLeon-Pennell KY;Meschiari CA;Jung M;Lindsey ML

文献摘要

参考文献

被引文献

相似文献

心血管疾病(CVD)是死亡的主要原因,在美国每年有60万人死亡,此外,心力衰竭占医疗保健支出的37%。基质金属蛋白酶(MMPs)在心肌梗死(MI)后增加,并与心力衰竭患者的左心室功能障碍相关。MMPs通过促进细胞外基质(ECM)更新和炎症信号传导来调节重塑过程。由于基质金属蛋白酶在心脏重塑过程中发挥的关键作用,有必要更好地了解基质金属蛋白酶的病理生理机制,包括MMP蛋白水解下游产物的生物学功能。未来的研究开发新的治疗靶点,抑制特定的MMP的行动,以限制心肌梗死后心力衰竭的发展是必要的。这本书的章节集中在MMPs后MI的作用,MMPs作为MI或心力衰竭的生物标志物的效率,以及MMPs及其裂解产物作为预防MI后心力衰竭的靶点的未来。
Cardiovascular disease (CVD) is the leading cause of death, accounting for 600,000 deaths each year in the U.S. In addition, heart failure accounts for 37% of healthcare spending. Matrix metalloproteinases (MMPs) increase after myocardial infarction (MI) and correlate with left ventricular dysfunction in heart failure patients. MMPs regulate the remodeling process by facilitating extracellular matrix (ECM) turnover and inflammatory signaling. Due to the critical role MMPs play during cardiac remodeling, there is a need to better understand the pathophysiological mechanism of MMPs, including the biological function of the downstream products of MMP proteolysis. Future studies developing new therapeutic targets that inhibit specific MMP actions to limit the development of heart failure post-MI are warranted. This book chapter focuses on the role of MMPs post-MI, the efficiency of MMPs as biomarkers for MI or heart failure, and the future of MMPs and their cleavage products as targets for prevention of post-MI heart failure.
DOI: 10.1074/jbc.m007674200
发表时间: 2001-03-30
影响因子: 4.8
作者:
Balbín, M;Fueyo, A;López-Otín, C
通讯作者: López-Otín, C
DOI: 10.1016/j.yjmcc.2014.09.007
发表时间: 2014-11
影响因子: 5
作者:
DeLeon-Pennell, Kristine Y.;Bras, Lisandra E. de Castro;Iyer, Rugmani Padmanabhan;Bratton, Dustin R.;Jin, Yu-Fang;Ripplinger, Crystal M.;Lindsey, Merry L.
通讯作者: Lindsey, Merry L.
DOI: 10.1002/jcp.20271
发表时间: 2005-07-01
影响因子: 5.6
作者:
Arikan, MC;Shapiro, SD;Mariani, TJ
通讯作者: Mariani, TJ
DOI: 10.1006/bbrc.1996.1677
发表时间: 1996-11-12
影响因子: 3.1
作者:
Chandler, S;Cossins, J;Wells, G
通讯作者: Wells, G
DOI: 10.1016/j.atherosclerosis.2004.01.009
发表时间: 2004-05-01
期刊: ATHEROSCLEROSIS
影响因子: 5.3
作者:
Furman, C;Copin, C;Rouis, M
通讯作者: Rouis, M